Evidence map›Paper›PMID 33083562›Full record

ArticleNPJ digital medicine2020

Age and environment-related differences in gait in healthy adults using wearables.

Matthew D Czech, Dimitrios Psaltos, Hao Zhang, Tomasz Adamusiak, Monica Calicchio, Amey Kelekar, Andrew Messere, Koene R A Van Dijk, Vesper Ramos, Charmaine Demanuele and 4 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Longitudinal associations between physical activity and preferred walking speed in community-dwelling older adults: a 4-year follow-up study.European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2026
    Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Matthew D CzechEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.ORCID 0000-0001-9954-7003
Dimitrios PsaltosEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.
Hao ZhangEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.
Tomasz AdamusiakEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.ORCID 0000-0002-0746-2916
Monica CalicchioEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.
Amey KelekarEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.
Andrew MessereEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.
Koene R A Van DijkEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.ORCID 0000-0001-6137-4282
Vesper RamosEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.
Charmaine DemanueleEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.
Xuemei CaiEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.ORCID 0000-0001-9822-9935
Mar SantamariaEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.
Shyamal PatelEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.
F Isik KarahanogluEarly Clinical Development, Pfizer, Inc., Cambridge, 02139 MA USA.ORCID 0000-0002-9162-8367

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Technological advances in multimodal wearable and connected devices have enabled the measurement of human movement and physiology in naturalistic settings. The ability to collect continuous activity monitoring data with digital devices in real-world environments has opened unprecedented opportunity to establish clinical digital phenotypes across diseases. Many traditional assessments of physical function utilized in clinical trials are limited because they are episodic, therefore, cannot capture the day-to-day temporal fluctuations and longitudinal changes in activity that individuals experience. In order to understand the sensitivity of gait speed as a potential endpoint for clinical trials, we investigated the use of digital devices during traditional clinical assessments and in real-world environments in a group of healthy younger (

Indexed as

Biomedical engineeringPredictive markersQuality of life

Identifiers

PMID33083562
PMCPMC7528045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.